News

Cost of Antibiotic Resistance Hits Private Payers


 

The third study, also unpublished work by Dr. Foster and her associates, was an Internet-based survey of more than 300 respondents recruited from MRSA chat rooms, listservs, and Google Adwords. Acknowledging the limitations of such surveys—particularly the bias toward younger, healthier Internet users with strong opinions—she described “some heart-rending responses,” including one from parents who felt they had to send their children away to prevent transmission.

Respondents reported a mean out-of-pocket expenditure of $2,251, including copays for office visits, prescription drugs, and hospital stays. Nearly 70% reported having private insurance (HMO or PPO), and 14% said they were uninsured, which approximately reflects the national average, Dr. Foster said.

“Individuals and households affected by drug resistance bear a large uncompensated burden in terms of out-of-pocket expenses and lost wages,” she concluded.

A related video is at www.youtube.com/InternalMedicineNews

Pages

Recommended Reading

IOM Urges Hepatitis Screening, Prevention
MDedge Internal Medicine
Flocked Swabs Beat Aspiration for Virus Recovery
MDedge Internal Medicine
Acyclovir Ineffective in Serodiscordant Couples
MDedge Internal Medicine
Antiretrovirals May Alter Cardiovascular Risk Profile
MDedge Internal Medicine
Condoms Give Partial Protection Against HSV-2
MDedge Internal Medicine
It's Unofficial: For Public, Flu Pandemic Is Over
MDedge Internal Medicine
Less Than a Quarter of U.S. Population Got H1N1 Vaccine
MDedge Internal Medicine
Mood Disorders in HIV May Be Drug Related
MDedge Internal Medicine
Online Program for Flu Assessment
MDedge Internal Medicine
Report Finds Low Vaccination Rates in U.S. Adults
MDedge Internal Medicine